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ABSTRACT: The current coronavirus (COVID-19) pandemic is a particular and rare 
situation. COVID-19 has affected and is likely to affect people from many countries, in 
many geographical locations. We are in the midst of a worldwide pandemic, with cities 
and even entire countries shutting down. The coronavirus has affected nearly every 
aspect of our lives, from school to work, to sports, to where we eat and what we do. All 
these changes affected people physically, but also psychologically.
It is understandable that during times like this, people may be feeling afraid, worried, 
anxious, and depressed due to the constantly changing alerts and media coverage re-
garding the spread of the virus. Hence, the main aim of our paper is to explore the link-
age between the coronavirus COVID-19 disease and mental health conditions, such as 
stress, anxiety and depression. Everyone may experience fear of the consequences of 
the infection with a potentially fatal new virus, and might experience mental stress, 
anxiety, loneliness, depression. Based on experience from past global serious viral ex-
periences, the development and implementation of mental health assessment, sup-
port, treatment, and services are crucial and pressing goals for the health response to 
the COVID-19 outbreak.
Human beings have an incredible ability to adapt and survive, through altruistic and 
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co-operative means. So for each one of us is important to look after ourselves and each 
other.
KEYWORDS: coronavirus COVID-19, stress, anxiety, depression, psychosocial support
INTRODUCTION
                                          “It’s easy to blame, it’s easy to politicize. It’s harder to tackle
                                      a problem together, and find solutions together”.
                                             (Tedros Adhanom Ghebreyesus, General Director of WHO)
Accounts of mental health and infectious diseases date to antiquity. Scientific appre-
ciation for the many complex relationships between mental health problems and viral 
diseases has rapidly expanded only in recent decades (Coughlin 2011; Prince et al. 
2007; Schuster, Bornovalova and Hunt 2012). Viral diseases and mental health condi-
tions are not recognized among the largest categories of disease burden globally.
Since the end of December 2019, the Chinese city of Wuhan reported a novel pneu-
monia caused by coronavirus 2019 (COVID-19) which is spreading both nationally and 
internationally (Novel Coronavirus Pneumonia Emergency Response Epidemiology Team 
2020:113). The virus has been named severe acute respiratory syndrome coronavirus 
2 (SARS-CoV-2). COVID-19 rapidly spread from a single city to the entire country. 
The sheer speed of both the geographical expansion and the sudden increase in the 
number of cases, suppressed and quickly overwhelmed health and public health ser-
vices in China, particularly in the city of Wuhan and the Hubei Province. Epidemic 
curves reflect what may be a mixed outbreak pattern, with early causes suggestive of 
a continuous common source, potentially a zoonotic spillover at the Huanan Seafood 
Wholesale Market, and later cases suggestive of a propagated source as the virus be-
gan to be transmitted from person-to-person (Battegay et al. 2020).
On January 30, the World Health Organization declared the novel coronavirus out-
break as an international emergency and on March 11, the WHO declared the glob-
al COVID-19 a pandemic (World Health Organization 2020). This new disease that 
emerged in Wuhan – China in late 2019, is currently having a significant impact world-
wide. The numbers of cases are changing quickly and national governments of every 
country are rapidly adopting measures that are a precaution to minimize the risk of 
exposure and spread.
Since the outset, the government of every country has been working closely with 
the Ministry of Health and local public health units to provide evidence and expertise 
for informed decisions and policies in regard to surveillance, case control manage-
ment, and infection control.
At this moment COVID-19 is affecting more than 27 countries, raising concern of 
widespread panic and increasing anxiety in individuals subjected to the (real or per-
ceived) threat of the virus. Importantly, these concerns arise with all infections, in-
cluding the flu and other agents, and the same universal precautions are needed and 
indicated for safety and the prevention of further transmission. There is widespread 
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community transmission of COVID-19 in each country, meaning that the sources of 
new infections are unknown. Everyone everywhere should act as if they have been 
exposed to COVID-19.
Pandemics affect individuals and societies on many levels, causing disruption. It is 
normal to feel stress and worry when there is a health event happening in the commu-
nity that is affecting people’s wellbeing, such as the coronavirus disease (COVID-19). 
Fear and panic have also been linked to outbreaks. As concerns over the perceived 
threat grow, people may start to collect masks and other medical supplies. This is of-
ten followed by anxiety-related behaviors, insomnia, and overall lower perceived state 
of health. Every person may be particularly vulnerable to the effects of widespread 
panic and threat.
THE MAIN CHARACTERISTICS OF THE CORONAVIRUS DISEASE 2019 
(COVID-19)
Coronaviruses are a group of viruses that can cause illness ranging from mild con-
ditions, such as a cold, to more serious illnesses such as pneumonia (Nanshon et al. 
2020). Recently, a new coronavirus was detected that had not been previously found in 
humans. The disease, called COVID-19, can be spread from person-to-person.
For the first time in 2003, the pathogen behind the SARS-CoV (severe acute respi-
ratory syndrome) outbreak in China was identified as a coronavirus (Chan-Yeung and 
Rui-Heng 2003). That outbreak is believed to have started when a coronavirus was 
transmitted from animals, especially cats, to humans, resulting in a type of disease 
called zoonosis (Hung 2003:375). These viruses were underlined in 2012, when an-
other virus was transmitted from camels to humans causing MERS-CoV (Middle East 
Respiratory Syndrome). That illness has killed 858 people to date, primarily in Saudi 
Arabia, representing approximately 34 percent of those infected (Hajjar, Memish, and 
Mcintosh 2013; De Wit et al. 2016).The comparisons with the current virus showed 
significant differences and similarities. Both MERS-CoV and SARS-CoV have much 
higher fatality rates (40% and 10% respectively). 
Although the current SARS-CoV-2 (also referred to as 2019-nCoV), shares 79% of 
its genome with SARS-CoV, it appears to be more transmissible (Phan et al. 2020). 
The virus activates immune cells and induces the secretion of inflammatory cytokines 
and chemokines into pulmonary vascular endothelial cells. The mean incubation pe-
riod is 14 days, with the 95th percentile of distribution at 5.5 days, though uncertainty 
remains. Studies have shown effective person-to-person transmission of 2019-nCoV 
even in the presence of isolation efforts in medical facilities (Phan et al. 2020). Trans-
mission in a health setting is a very serious threat. While further study is required, it 
appears that asymptomatic persons are also potential sources of 2019-nCoV infection 
(Wan et al. 2020; Rothe et al. 2020).
There are two ways a coronavirus can be transmitted via air. In a droplet form, the 
coronavirus is airborne for a few seconds after someone sneezes or coughs. It is able 
to travel only a short distance before gravitational forces pull it down. Someone close 
enough for the virus particles to reach in that brief period can therefore be infected. 
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It can be anyone who comes into contact with virus-containing droplets that fall onto 
a surface. The new coronavirus can survive on surfaces for several hours; hence is the 
importance of hand-washing after touching a surface in a public place. The Wuhan 
scientists concluded that the virus aerosol is a potential transmission pathway (Jiang 
et al. 2020). 
Huang et al. (2020:499) first reported clinical features of 41 patients confirmed to 
be infected with COVID-19 on January 2, 2020. The initial symptoms included fever, 
cough, dyspnea, myalgia or fatigue, sputum production, headache, hemoptysis and 
diarrhea. Most people with COVID-19 have mild to moderate symptoms and fully re-
cover without complications. Less commonly, COVID-19 may lead to pneumonia, hos-
pitalization or death.
People who are at most risk for severe illness are adults aged 50 or older, or those 
who have chronic health conditions, such as: lung disease, heart disease, diabetes, 
cancer, and weakened immune system. 
COVID-19, OUTBREAKS AND PANDEMICS
It is a frightening time. We are in the midst of a worldwide pandemic, with cities and 
even entire countries shutting down. Some of us are in areas that have already been af-
fected by coronavirus. Others are bracing for what may come. And all of us are watch-
ing the headlines and wondering: “What is going to happen next?”.
COVID-19 has and is likely to affect people from many countries, in many geograph-
ical location. The governments of all countries decided to restrict personal move-
ments, public events, and business activities of their people, media outlets worldwide 
have accelerated the fear-based headline machine into overdrive. There are hourly 
updates of new cases, possible deaths, and official briefings, as well as prognostication 
about future calamity (World Health Organization 2020).
Many streets in cities around the world are empty. Flights to and from affected 
parts of the world have been grounded. Scientific or business conferences have been 
cancelled. Museums are closed. People have to stay at home. It is clear that, when 
public health authorities have to face outbreaks, national and international policies 
and interventions have been used. Getting people to cooperate towards the goal of 
contingent self-imposed quarantines, washing hands, limiting travel and gatherings, 
reducing number of free riders to a minimum and avoiding extreme risk perceptions 
(panic or anxiety) is as important as closing schools and increasing the number of 
beds in intensive care units. At this moment, it is very difficult to tell how many lives 
were saved with the actions to reduce the pandemic.
COVID-19 is new virus and has not been well understood yet. We do not have a vac-
cine for coronavirus, but we have antiviral therapy, which might be effective against 
coronavirus and maybe life will return to normal in every part of the world.
MENTAL HEALTH IMPACTS OF CORONAVIRUS COVID-19
Public health emergencies, such as the outbreak of the coronavirus disease 2019 
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(COVID-19), are a stressful time for both people and communities. Fear and anxiety 
about a disease can lead to social stigma toward people, places or things. For exam-
ple, stigma and discrimination can occur to people with a disease, such as COVID-19, 
within a population or a nation, even though not everyone belongs to that population 
or to a region that is specifically at risk for the disease. It is very clear that stigma hurts 
everyone by creating fear or anger towards other people. COVID-19 has wrecked our 
way of life in a manner that probably has not been seen for a long time. There has been 
a lot of fear, anxiety and stress related to this new situation in our life.
In fact, the coronavirus has affected nearly every aspect of our lives from school to 
work, to sports, to where we eat and what we do. All these changes being forced upon 
us can stir up anxiety within us. Facing these critical situations, everyone is at risk 
of developing psychological distress and mental health symptoms such as anxiety, 
depression, and loneliness (Barlow and Michelle 2000). There are likely to be mul-
tiple biological and behavioral pathways that account for linkages between mental 
health conditions and viral disease, such as coronavirus disease 2019 (COVID-19) and 
the specific mechanisms can vary by viral disease. Mental conditions such as depres-
sion can delay help-seeking or reduce the likelihood of detecting other health condi-
tion including communicable diseases (Basco, Krebaum, and Rush 1997). Depression 
and psychological stress have shown to have a number of biological effects including 
reduced cell-mediated immunity and increased inflammatory processes (Heymann 
2008). A further issue is that coronavirus can directly affect the brain and result in 
mental health conditions such as stress, anxiety or depression.
Communities can be affected by COVID-19 in many ways. People are separated 
from their loved ones, due to illness or death. Health workers need to deal with a high 
workload and a lot of stress. Those associated with COVID-19 can be vulnerable to 
social stigma, which is worsening their distress and isolation. In fact, whole commu-
nities nay experience the fear and suffering that disease outbreaks often cause. Poten-
tial mental health impacts on people who are directly affected include:
- Increased anxiety for oneself and others;
- Psychological distress;
- Social isolation;
- Interruption of employment or study;
- Impact on normal daily routines and functioning.
Most people will manage with the support of family and friends, but others may 
need some extra help to keep things on track.
COVID-19, STRESS AND POSTTRAUMATIC STRESS DISORDER
Stress is a normal psychological response to an abnormal situation. As such, it is a part 
and a parcel of our lives. It enables our body to adapt to the multiplicity of positive or 
negative events that we experience, such as birth, marriage, loss of employment, etc. 
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Stress comes and goes on its own, depending onthe involved factors (Beck and Sloan 
2012).
The outbreak of the coronavirus disease (COVID-19) may be stressful for people. 
Everyone reacts differently to stressful situations. The way a person responds to the 
outbreak can depend on his/her background, the things that make him/her different 
from other people, and the community the person lives in.
Stress during an infectious outbreak can include:
- Fear and worry about our own health and the health of our loved ones;
- Changes in sleep or eating patterns;
- Problems with memory or concentration;
- Worsening of chronic health problems;
- Increased use of alcohol, tobacco, or other things.
At the same time, people experience psychologically traumatic stressors “outside 
the range of usual human experience”. Many of those subjected to psychologically 
traumatic stressors, experience them in dreams or memory with an associated un-
pleasant feeling, changes in affect and experience of trauma usually dominant in fre-
quency and intensity, and themselves do not represent signs of posttraumatic stress 
disorder.
Individuals exposed to trauma, such as a coronavirus pandemic, fail to recover 
spontaneously and experience lingering symptoms that mirror their initial reaction to 
an event. These individuals develop an acute stress disorder or reaction that greatly 
interferes with their ability to return to their family and their social and work routines 
(Coughlin 2012). Within a month or so, such acute reactions usually remit, and the 
person returns to his or her pre-trauma routine, with a restored a state of homeostasis. 
For others, this acute reaction fails to remit and symptoms persist, becoming chronic, 
often debilitating posttraumatic stress disorder (Blaunchard and Buckley 1999).
RELATIONSHIP BETWEEN COVID-19 AND ANXIETY
Contrary to fear, which is a response to a well-defined and very real threat, anxiety is 
a response to a vague or unknown threat. Anxiety is manifested when we believe that 
a dangerous or unfortunate event may take place and one expects it. Everyone expe-
riences anxiety at their own individual degree and intensity. The way an anticipated 
event is perceived will greatly influence the intensity of the experience of anxiety.
The symptoms of anxiety are persistent are not restricted to, or markedly increased, 
in any particular set of circumstances. With headlines warning us of international 
terrorism, global warming, economic uncertainty, or viral diseases, such as COVID-19, 
all of us are likely to be a little more anxious these days. As an everyday emotion, 
anxiety – “the fight or flight” response can be a good thing, prompting us to take extra 
precautions. But when anxiety persists in the absence of a need to fight or flee, it can 
not only interfere with our daily lives, but it can also undermine our physical health 
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(Wittchen and Hoyer 2001). Evidence suggests that people with anxiety disorder are at 
greater risk for developing a number of acute or chronic medical conditions. They also 
have more severe symptoms and a greater risk of death when they become ill (Brown 
and Barlow 2001).
While the nature of most differential experiences is not yet clear, evidence suggests 
that stressful life plays a significant role in the onset and persistence of anxiety. Blaz-
er, Hughes and George (2016:1181) noted that the occurrence of one or more negative 
life events increased the risk of developing anxiety in the following year. Among the 
other theories, uncontrollability over the environment (Barlow 2001), psychosocial 
trauma (Borkovec 1994), and insecure attachment to caregivers (Borkovec 1994) have 
been conceptualized as risk factors for anxiety.
Anxiety can appear in a variety of physical, psychological, emotional and behavior-
al ways for any given individual in this period of the unknown COVID-19. There is a 
characteristic pattern which consists of the following features (Bystritsky et al. 2013):
- Autonomic over-activity which is most often experienced as sweating, palpita-
tions, dry mouth, dizziness, etc.;
- Psychological and emotional arousal, which can be manifested as virus-related 
worries and insecurity, feelings of being overwhelmed by events, self-verbaliza-
tion that does not always reflect reality, negative vision of things or daily events, 
feelings of discouragement, insecurity, sadness, anger;
- Sleep disturbances, which include difficulty falling asleep and persistent wor-
rying thoughts. Some people might have terrors and wake up suddenly feeling 
extremely anxious.
- Behavioral symptoms, such as: difficulty concentrating, irritability or aggres-
sion, crying, withdrawal or insularity, difficulty in making decisions.
Patients with confirmed or suspected COVID-19 may experience fear of the con-
sequences of the infection with a potentially fatal new virus, and those in quarantine 
might experience boredom and loneliness. In addition, symptoms of the infection, 
such as fever, hypoxia, and cough, as well as adverse effects of the treatment, such 
as insomnia caused by corticosteroids, could lead to worsening anxiety and mental 
distress. COVID-2019 has been repeatedly described as a killer virus, which has per-
petuated the sense of danger and uncertainty among health workers and the public 
(Weshling et al. 2020). In the early phase of the SARS outbreak, a range of psychiat-
ric morbidities including depression, anxiety, panic attack, psychomotor excitement, 
psychotic symptoms, delirium, and even suicidality, were reported (Lee, Wong, and 
McAlonan 2007). Furthermore, mandatory contact tracing and 14 days quarantine, 
which form a part of public health responses to the COVID-19 pneumonia outbreak, 
could increase patient’s anxiety and guilt about the effects of contagion, quarantine, 
and stigma on their families and friends.
At the same time, health professionals are vulnerable to high risk of infections and 
mental health problems. They may also experience fear of contagion and spreading of 
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the virus to their families, friends, or colleagues. They experience high level of stress, 
anxiety and depressive symptoms (Wang et al. 2020). Similar concerns about the men-
tal health, psychological adjustment, and recovery of healthcare workers treating and 
caring for patients with COVID-19 are now arising everywhere.
FRAMEWORK FOR UNDERSTANDING THE LINKAGE BETWEEN                      
DEPRESSION AND COVID-19
We are living in the dark time of health where we are surrounded by thousands of con-
tagious viruses, bacteria and other pathogens in the environment that use our bodies 
as their long-term home. Once these microbes have insinuated themselves into our 
metabolisms, they frequently remain there for life, where they can slowly or rapidly 
degrade our physical and mental health. Pathogens living in an individual’s body will 
reduce the person’s mental and physical activities. Our bodies are considerably over-
burdened with persisted viral infections which often alter our physiology.
The burden of depression is rising both for the individual, the family, and for the 
society. Currently most people who are treated for depression are partially responsive 
or non-responsive. New tools are needed. One of these tools involves a focus on the 
infections that are often associated with depression (Mason, Mathews, and Han 2013).
On the other side, we did not know anything about the mechanism of the linking 
between COVID-19 and depression among people. Although the effects of the coro-
navirus on mental health have not been systematically studied, it is anticipated that 
COVID-19 will have rippling effects, especially based on current public reactions. It is 
normal to feel sad about some of the news we are hearing, because people are dying. 
This is a very scary and concerning situation. This new virus in endemic and pandemic 
forms, is a major factor in morbidity and mortality globally.
Depression is a state of low mood aversion to activity that can affect a person’s 
thoughts and behavior, feelings and physical wellbeing (American Psychiatric Associ-
ation 2013). Depressed people may feel sad, anxious, empty, hopeless, helpless, worth-
less, guilty, irritable or restless. They may lose interest in activities that once were 
pleasurable, experience loss of appetite or begin overeating, or experience problems 
of concentrating, remembering details or making decisions, and may contemplate 
or even attempt suicide. Insomnia, excessive sleeping, fatigue, loss of energy, aches, 
pains or digestive problems that are resistant to treatment may be present (Attkisson 
and Zich 1990).
Depression in this coronavirus pandemic is a normal reaction to certain life events. 
It is absolutely natural for each of us to feel fear, sad, loneliness and isolation during 
this time.
As Peter Kinderman (2020) said:
COVID-19 will affect us all. Our lives are changing quickly, we are isolating our-
selves and social distancing which cannot be good for our mental health. The 
inevitable uncertainty will also put pressure or our emotions and resilience. It 
is normal to feel afraid, depressive and worried in the face of uncertainty and 
adversity, but there are also things we can do to look after our mental health and 
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wellbeing during these times.
THE ROLE OF PSYCHOSOCIAL SUPPORT FOR MANAGING STRESS, ANXIETY 
AND DEPRESSION DURING CORONAVIRUS DISEASE(COVID-19)
It is understandable that during times like this, people may be feeling afraid, worried, 
anxious, and overwhelmed by the constantly changing alerts and media coverage re-
garding the spread of the virus. So it is very important to stay informed, to follow men-
tal health and wellbeing tips and strategies and to continue to look after ourselves and 
each other during these difficult times.
Psychosocial treatment consists of strategies that target excessive, uncontrollable 
stress, concern and persistent excessive arousal. Psychiatrists and psychologists are 
uniquely situated to help both their patients and the great community understand 
the potential impact of the virus and help patients, families and society deal with this 
latest threat. Treatment plans, progress, reports and status updates should be given 
to the person and his/her family. Emotional and behavioral response are a part of an 
adaptive response to extraordinary stress, and psychotherapy techniques based on the 
stress-adaptive model might be helpful (Folkman and Greer 2000). It has also been 
recognized, that after this large COVID-19 pandemic, survivors will need prolonged 
mental health care when facing the task of rebuilding their lives (Keane, Weathers and 
Fox 2000).
From the standpoint of care and support, it is very important to recognize three 
phases of a/an endemic/pandemic (before, during and after). Therefore, we try to pres-
ent the main psychosocial manifestations in an epidemic, broken down by phases and 
corresponding actions.
Psychological assistance services, including telephone, internet and applica-
tion-based counseling or intervention, have been widely deployed by local and na-
tional mental health institutions in a response to the COVID-19 outbreak. Hence the 
availability of transparent appropriate, and timely information is vital for the emotion-
al restraint of family members and for keeping the general population calm (Sandman 
and Lanard 2005). So, the  healthy sector should coordinate with law enforcement and 
humanitarian aid workers for crowd control. Entry to health care facilities should also 
be controlled. 
Each one of us is part of a community, so it is our human nature to care for one an-
other, as we, in turn, seek the social and emotional support of others. 
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Table 1. Phases/psychosocial manifestations in the population and mental health actions
Phases/psychosocial manifestations in the 
population
Mental health actions
Before:
- Sense of inevitability, with a high level of ten-
sion in the population,
- Maximization of preexisting characteristics 
(positive or negative);
- Worry, fear, tension, anxiety, depression, insom-
nia…
- Communicate risk to the population, with emphasis on 
vulnerable groups (children, adolescents, old persons, 
persons who contracted the disease and survived, persons 
with chronic physical illness).
- Locate personnel trained in mental health.
- Establish psychosocial support and counseling groups.
- Detect psychosocial risk factors.
- Encourage collective spirit and support community par-
ticipation.
- Organize mental health services for an adequate emer-
gency response (mobile teams, crisis intervention units 
and services in general hospitals).
During:
- Loss of initiative.
- Feelings of fear, worry, vulnerability.
- Adaptation to changes in the usual patterns of 
life (restricted movement, wearing masks, reduc-
tion in direct physical contact, closure of schools 
or universities, closure of shops….).
- Anxiety, depression, stress, panic attacks, agita-
tion, somatic disorder of psychological origin.
- Evaluation of the psychosocial needs of the population.
- Support of the core actions of early detection, reporting, 
care and containment.
- Mass communication, information and guidance on: what 
is happening, what is being done, and what the people 
should do.
- Provide psychosocial care and support (individual and 
group-based) for affected people, families, and communi-
ties.
- Create opportunities for mutual support in the commu-
nity.
- Create a menu of personal self-care activities that the per-
son enjoys, such as spending time with family, exercising or 
reading a book.
- Take a break from media coverage of COVID-19.
- Support everyone to be connected with others.
- Promote work rotation and organize working hours ap-
propriately.
- Take time to talk with children or teens about the 
COVID-19 in a way that they can understand.
- Protect human rights (migrants, refugees, prisoners, peo-
ple with disabilities).
- Specialized services for pandemic settings.
After:
- Fear of a new epidemic.
- Social and mental health conditions: depression, 
posttraumatic stress, violence, depression, alco-
hol or drug abuse.
- A slow, progressive recovery process begins.
- Maintain a mass communication strategy to facilitate 
recovery.
- Implement individual and group-based mental health 
care for the affected persons, families and communities.
- Support that new life projects should be fostered and 
encouraged.
Source: own elaboration.
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CONCLUDING REMARKS
In this review we summarized studies and experiences which indicate important rela-
tionship between stress, anxiety, depression and viral diseases such as the coronavirus 
disease 2019 (COVID-19).
In today’s world, a microbial disaster is no longer a possibility, but a certainty: “As 
human impact on the earth increases exponentially, the chances for unpleasant sur-
prises from the microbial world will also grow. The virus spreads quickly, because no 
one has any significant immunity to the novel strain and the illness it causes can be 
usually severe” (Schnurr and Green 2004:21).
The COVID-19 outbreak that began in China in December 2019, caused more than 
779.741 cases and 38.721 deaths in the world (Worldometer 2020, Last updates March 
31, 2020). The WHO has reported more than 220.000 cases and 11.987 deaths associ-
ated with COVID-19 in the European region (Kluge 2020). That means that globally 
roughly about 6 out of every 10 cases, and 7 out of every deaths, are reported from the 
European region (Kluge 2020).
Global society is more interconnected than ever, and emerging pathogens do not 
respect geopolitical boundaries. Proactive investment in public infrastructure and ca-
pacity is critical to improve international surveillance, cooperation, coordination and 
communication about this major outbreak and to be even better prepared to respond 
to future new public health threats.
Most of the people do not have resources and mental strength to adapt to this type 
of situation. We are faced with “an invisible enemy”, our lives continue to be disrupted 
and social distancing becomes necessary. The fear and anxiety will increase, every-
one has unreal thoughts about the new day and everyone feels isolated or depressive. 
During the outbreak, “generalized fear and fear-induced over-reactive behavior were 
common among the public”, while depression, anxiety and post-traumatic stress dis-
order all emerged. The negative effects of stigmatizing a language, such as attaching a 
region or an ethnicity to the virus, or blaming people for transmission, exacerbate the 
sense of fear at a macro level. Hence, a sense of hope instead of fear could allow lead-
ers and everyday citizens to better cooperate with another which each other is a vital 
element in defeating this outbreak. As a society, we must work together with a sense 
of empathy. As individuals, we must inform ourselves of the facts, stay connected to 
the people we love and be kind to each other.
Among the many experiences discussed regarding psychosocial interventions in 
the event of COVID-19 outbreak in the world, special attention has been dedicated to:
- The need for involving communities before, during, and after the epidemic/
pandemic;
- To investigate in the training and supervision of workers to provide psychoso-
cial support and mental health care;
- To improve the care of vulnerable groups of persons;
- To integrate the psychosocial and mental health interventions within the 
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framework of public health.
In any biological disaster, themes of fear, anxiety, depression and stigmatization 
are common and may act as barriers to appropriate medical and mental health inter-
ventions (Pierini and Stuifbergen 2010). Based on experience from past serious novel 
pneumonia outbreaks globally and the psychosocial impact of viral epidemics, the 
development and implementation of mental health assessment, support, treatment, 
and services are crucial and pressing goals for the health response to the 2019-nCoV 
outbreak.
Human beings have an incredible ability to adapt and survive, through altruistic 
and co-operative means. So for each one of us is important to look after ourselves and 
each other.
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